Position in LLY
as of Jun 30, 2026
· filed Jul 8, 2026
Position Value
$17,223,816
+$4,048,111 QoQ
Shares Held
14,360
+0.2% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.66%
of 13F equity value
Holder Rank
#27
of 297 holders
Holding Since
Mar 2021
22 quarters on record
Voting authority
Sole 88.58635097493035.ToString("F0")%
Shared 0.ToString("F0")%
None 11.413649025069637.ToString("F0")%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Hennion & Walsh Asset Management, Inc. holds $55,949,166 across 10 Drug Manufacturers - General names. LLY ranks #1 (30.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
This page
|
14,360 | $17,223,816 | |
| 2 | JNJ |
Johnson & Johnson
|
43,755 | $11,112,457 | |
| 3 | MRK |
Merck & Co., Inc.
|
72,515 | $9,318,177 | |
| 4 | ABBV |
AbbVie Inc.
|
23,832 | $5,997,084 | |
| 5 | GRFS |
Grifols SA
|
592,173 | $4,192,584 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
28,507 | $3,601,574 | |
| 7 | AMGN |
Amgen Inc
|
7,665 | $2,775,649 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
18,045 | $1,039,752 |
All Filings in LLY
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $17,223,816 | 14,360 | Shares | Sole | 2026-07-08 | |
| 2026-03-31 | $13,175,705 | 14,325 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $15,104,628 | 14,055 | Shares | Sole | 2026-01-14 | |
| 2025-09-30 | $11,052,055 | 14,485 | Shares | Sole | 2025-10-22 | |
| 2025-06-30 | $11,700,745 | 15,010 | Shares | Sole | 2025-08-07 | |
| 2025-03-31 | $11,631,290 | 14,083 | Shares | Sole | 2025-04-10 | |
| 2024-12-31 | $11,516,696 | 14,918 | Shares | Sole | 2025-01-15 | |
| 2024-09-30 | $12,816,893 | 14,467 | Shares | Sole | 2024-10-22 | |
| 2024-06-30 | $18,016,156 | 19,899 | Shares | Sole | 2024-07-19 | |
| 2024-03-31 | $16,077,321 | 20,666 | Shares | Sole | 2024-04-17 | |
| 2023-12-31 | $14,454,084 | 24,796 | Shares | Sole | 2024-01-10 | |
| 2023-09-30 | $14,461,688 | 26,924 | Shares | Sole | 2023-10-27 | |
| 2023-06-30 | $14,614,823 | 31,163 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $9,906,980 | 28,848 | Shares | Sole | 2023-04-20 | |
| 2022-12-31 | $11,328,601 | 30,966 | Shares | Sole | 2023-01-12 | |
| 2022-09-30 | $10,290,613 | 31,825 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $12,151,816 | 37,479 | Shares | Sole | 2022-07-19 | |
| 2022-03-31 | $12,166,429 | 42,485 | Shares | Sole | 2022-04-26 | |
| 2021-12-31 | $11,084,432 | 40,129 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $9,293,293 | 40,222 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $7,902,373 | 34,430 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $5,960,678 | 31,906 | Shares | Sole | 2021-05-17 | |
| No filing history on record for this holder in this stock. | ||||||